The Wall Street Journal reported that Allergan Inc. (NYSE: AGN) approached Salix Pharmaceuticals (Nasdaq: SLXP) for a possible acquisition. Shares of Allergan soared $6.21 to close at $161.82 while Salix stock rocketed $21.63 to close at $160.80.
Allergan approaches Salix
August 19, 2014 at 17:55 PM EDT